Javelin Pharmaceuticals
Javelin Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the research, development, and commercialization of products.
Launch date
Employees
Market cap
-
Enterprise valuation
$95m (Public information from Dec 2009)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $32.0m | Growth Equity VC | |
$750k | Grant | ||
$95.0m Valuation: $95.0m | Acquisition | ||
| Total Funding | $32.8m | ||
Related Content
Recent News about Javelin Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.